Charleston Firm Med-Ally’s Assets Acquired by Resonetics

Charleston, SC, January 16, 2026

Resonetics has strategically acquired manufacturing assets and intellectual property from Charleston-based Med-Ally, a company focused on the neuromodulation market. This acquisition aims to strengthen Resonetics’ Medical Power business, integrating advanced pulse generator manufacturing processes. The move highlights the ongoing innovation within the medical technology sector and supports the growth of Charleston’s local economy by showcasing its vibrant life sciences industry.

Charleston, SC

Charleston Firm Med-Ally’s Assets Acquired by Resonetics

This strategic move highlights the ongoing innovation and growth within the medical technology sector, promising new opportunities for the industry.

Driving Innovation in Medical Technology

In a significant development for the medical technology landscape, Resonetics has announced the acquisition of manufacturing assets, process know-how, and intellectual property (IP) related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally. Med-Ally, a design and development company focused on the neuromodulation market, is based in Charleston, South Carolina.

This acquisition underscores the dynamic nature of the life sciences industry, where strategic investments drive progress and expand capabilities. For the Charleston area, this demonstrates the continued contribution of local entrepreneurs and specialized firms like Med-Ally to the broader medical device sector. The transaction reflects a proactive approach to fostering innovation and enhancing the capabilities within the highly specialized field of bioelectronics.

A Strategic Integration for Enhanced Medical Solutions

Resonetics, a global leader in advanced engineering and manufacturing solutions for the medical device industry, aims to strengthen its Medical Power business through this acquisition. The integration combines Resonetics’ existing implantable battery technologies with Med-Ally’s advanced pulse generator manufacturing processes. This creates a more comprehensive solution, enabling Resonetics to offer an integrated system from the energy source to the active implantable device.

This combined capability is particularly relevant for expanding markets such as neuromodulation, brain-computer-interface (BCI), and cardiac rhythm management (CRM). The ability to provide an end-to-end solution can streamline development and manufacturing for customers, potentially accelerating the availability of next-generation medical devices.

Med-Ally’s Contribution to Lowcountry Innovation

Med-Ally, founded in 2011 by Raja Hitti and John Mulvihill, has been a notable contributor to the Charleston area’s medical device industry. The company specialized in designing, developing, and manufacturing active implantable medical device systems, with a particular focus on neuromodulation technology, such as their VersaStim® platform. This technology aims to treat various conditions, including movement disorders, spinal cord injuries, chronic pain, and traumatic brain injuries.

Med-Ally’s operations were established in Goose Creek, South Carolina, within the Charleston International Manufacturing Center. The facility included a Class 7 cleanroom, essential for the fabrication of implantable devices, and contributed to local job creation with an investment of $2.38 million and a projection of 90 new jobs in 2018. The company’s presence highlighted the region’s appeal for specialized manufacturing and its supportive environment for life sciences businesses.

Resonetics’ Expanding Portfolio and Market Vision (Nationwide)

This acquisition marks Resonetics’ third notable transaction in the last twelve months, signaling a clear strategy to expand its capabilities in niche manufacturing technologies within the medical device industry (Nationwide). Previously, Resonetics added nitinol gun-drilling and insert- and micro-molding through acquisitions from Medical Component Specialists and Eden Holdings (Nationwide). Resonetics, established in 1987, is known for its advanced engineering and micro-manufacturing solutions, supporting specialities like cardiovascular, diabetes, and neurovascular applications (Nationwide).

The acquired assets from Med-Ally will be transferred to an existing Resonetics facility, a common practice in strategic acquisitions designed to consolidate operations and achieve greater efficiency. This consolidation is expected to further enhance Resonetics’ position as a comprehensive partner for next-generation neuromodulation devices (Nationwide).

Impact on the Medical Device Industry and Charleston’s Economy

The medical device manufacturing industry is a significant driver of economic growth and job creation (Nationwide). Acquisitions like this are a testament to the continuous drive for innovation and efficiency in the sector. They often lead to a more robust supply chain and increased investment in research and development, ultimately benefiting patients through advanced medical solutions (Nationwide).

Charleston, with its growing life sciences talent pool, over 400 medical device and pharmaceutical manufacturers, and a supportive business environment, continues to be an attractive location for medtech companies (State-level). While Med-Ally’s assets are relocating, the entrepreneurial spirit and specialized knowledge cultivated within the company remain a part of the Lowcountry’s rich economic fabric, demonstrating how local innovation can attract larger industry players and contribute to the national medical technology landscape (Nationwide).

Looking Ahead: Supporting Charleston’s Economic Future

The acquisition of Med-Ally’s specialized assets by Resonetics highlights the ongoing evolution and investment within the medical device sector. It underscores the value of entrepreneurial ventures that push the boundaries of medical technology. As Charleston’s economy continues to diversify and grow, particularly in the life sciences, supporting small businesses and innovative startups remains crucial. Their determination not only creates jobs but also positions our community at the forefront of vital industries. We encourage residents and local leaders to continue championing policies that foster a dynamic business environment, ensuring Charleston remains a hub for growth and personal achievement.

Frequently Asked Questions

What did Resonetics acquire from Med-Ally?

Resonetics acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally.

Where was Med-Ally located?

Med-Ally was based in Charleston, South Carolina, with operations located in Goose Creek, South Carolina, within the Charleston International Manufacturing Center.

What is the purpose of this acquisition for Resonetics?

The acquisition strengthens Resonetics’ Medical Power business by combining its implantable battery technologies with Med-Ally’s advanced pulse generator manufacturing processes, enabling an integrated solution from energy source to active implantable device.

Which markets will benefit from the combined capabilities?

The combined capabilities will serve the expanding neuromodulation, brain-computer-interface (BCI), and cardiac rhythm management (CRM) markets (Nationwide).

Will Med-Ally’s assets remain in Charleston?

No, the acquired assets from Med-Ally will ultimately be transferred to an existing Resonetics facility (Nationwide).

Key Features of the Resonetics-Med-Ally Acquisition

Deeper Dive: News & Info About This Topic

HERE Resources

Author: hereknowledge